MODERNA'S stock soared on Tuesday after the coronavirus vaccine maker reported progress in developing a preventive shot for a deadly form of skin cancer.

The company said a possible melanoma vaccine that it was studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details